PL397785A1 - Composition and preparation containing thioproline and ergothioneine, the use of thioproline and ergothioneine and a method for protecting skin against the extrinsic aging process - Google Patents
Composition and preparation containing thioproline and ergothioneine, the use of thioproline and ergothioneine and a method for protecting skin against the extrinsic aging processInfo
- Publication number
- PL397785A1 PL397785A1 PL397785A PL39778512A PL397785A1 PL 397785 A1 PL397785 A1 PL 397785A1 PL 397785 A PL397785 A PL 397785A PL 39778512 A PL39778512 A PL 39778512A PL 397785 A1 PL397785 A1 PL 397785A1
- Authority
- PL
- Poland
- Prior art keywords
- thioproline
- ergothioneine
- composition
- preparation containing
- extrinsic aging
- Prior art date
Links
- DZLNHFMRPBPULJ-VKHMYHEASA-N L-thioproline Chemical compound OC(=O)[C@@H]1CSCN1 DZLNHFMRPBPULJ-VKHMYHEASA-N 0.000 title abstract 5
- 230000032683 aging Effects 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- SSISHJJTAXXQAX-ZETCQYMHSA-N L-ergothioneine Chemical compound C[N+](C)(C)[C@H](C([O-])=O)CC1=CNC(=S)N1 SSISHJJTAXXQAX-ZETCQYMHSA-N 0.000 title 2
- 229940093497 ergothioneine Drugs 0.000 title 2
Landscapes
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Wynalazek dotyczy kompozycji zawierajacej tioproline i ergotioneine w synergicznie skutecznej ilosci oraz preparatu zawierajacego tioproline i ergotioneine w synergicznie skutecznej ilosci. Wynalazek dotyczy ponadto zastosowania kompozycji zawierajacej tioproline i ergotioneine do spowalniania, przeciwdzialania, zapobiegania procesowi starzenia zewnatrzpochodnego oraz sposobu spowalniania, przeciwdzialania, zapobiegania procesowi starzenia zewnatrzpochodnego skóry.The invention relates to a composition containing thioproline and ergotioneine in a synergistically effective amount and a preparation containing thioproline and ergotioneine in a synergistically effective amount. The invention further relates to the use of a composition containing thioproline and ergotioneine for slowing, counteracting, preventing extrinsic aging and a method of slowing down, counteracting, preventing extrinsic aging.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL397785A PL223232B1 (en) | 2012-01-12 | 2012-01-12 | Composition and preparation containing thioproline and ergothioneine, the use of thioproline and ergothioneine and a method for protecting skin against the extrinsic aging process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL397785A PL223232B1 (en) | 2012-01-12 | 2012-01-12 | Composition and preparation containing thioproline and ergothioneine, the use of thioproline and ergothioneine and a method for protecting skin against the extrinsic aging process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL397785A1 true PL397785A1 (en) | 2013-07-22 |
| PL223232B1 PL223232B1 (en) | 2016-10-31 |
Family
ID=48877630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL397785A PL223232B1 (en) | 2012-01-12 | 2012-01-12 | Composition and preparation containing thioproline and ergothioneine, the use of thioproline and ergothioneine and a method for protecting skin against the extrinsic aging process |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL223232B1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250134866A1 (en) * | 2022-02-03 | 2025-05-01 | Jan Trampota | Commensal signalling compounds for treating or preventing microbiome dysfunction in the skin or mouth |
-
2012
- 2012-01-12 PL PL397785A patent/PL223232B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL223232B1 (en) | 2016-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016500511A1 (en) | Selective grp94 inhibitors and uses thereof | |
| BR112016014410A2 (en) | neoantigen vaccine combination therapy | |
| NZ628294A (en) | Compositions and methods of use of phorbol esters for the treatment of stroke | |
| PH12014502757B1 (en) | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases | |
| MY197723A (en) | Vaccine compositions for the prevention of dengue virus infection | |
| PH12014502875A1 (en) | Vaccine compositions for prevention against dengue virus infection | |
| MY181602A (en) | Isochromene derivatives as phosphoinositide 3-kinases inhibitors | |
| NZ702087A (en) | Pharmaceutical compositions and treatment of mastitis | |
| PH12015502405B1 (en) | Methods and compositions for wound healing | |
| EP3061452A4 (en) | Use of icaritin in preparing medicament for preventing or treating hematocytopenia | |
| MX2014011855A (en) | SYSTEMS AND METHODS TO TREAT AN ADVERSE PHARMACODYNAMIC RESPONSE INDUCED BY OPIOIDES. | |
| PH12017500615A1 (en) | Ophthalmic composition comprising cyclosporine and trehalose | |
| EA201591507A1 (en) | TREATMENT OF MULTIPLE SCLEROSIS BY LACHINIMODOM | |
| MX2015013240A (en) | A method of providing ocular neuroprotection. | |
| MX2015000485A (en) | Treatment of multiple sclerosis with combination of laquinimod and fampridine. | |
| ZA201409073B (en) | Compositions and methods for treating or preventing pneumovirus infection and associated diseases | |
| MX2015012580A (en) | The use of sdf-1 to mitigate scar formation. | |
| UA113859C2 (en) | SPIROTIENOPIRAN-PIPERIDINE DERIVATIVES AS AN ORL-1 RECEIVER ANTAGONS FOR THEIR APPLICATION IN THE TREATMENT OF ALCOHOLIC DEPENDENCE AND ABUSE | |
| EA201491581A1 (en) | ВЕЗИКУЛЯРНЫЕ КОМПОЗИЦИИ | |
| PL397785A1 (en) | Composition and preparation containing thioproline and ergothioneine, the use of thioproline and ergothioneine and a method for protecting skin against the extrinsic aging process | |
| MX362111B (en) | A method of improving liver function. | |
| NZ629475A (en) | Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines | |
| HUE040124T2 (en) | Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain | |
| PL402105A1 (en) | Composition and formulation containing rosmarinic acid and thioproline, the use of this composition and a method for protecting the skin from the outside originating aging | |
| MX2016003763A (en) | Laquinimod combination therapy for treatment of multiple sclerosis. |